ArticleAging clinical and experimental research2025
A concise instrument for screening cognitive impairment: validation in a geriatric population.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Turkish Cross-Cultural Adaptation of the BRIEF-MPI in Older Adults with Cancer: Convergent and Discriminative Validity Compared with the G8 and Clinical Frailty Scale.Healthcare (Basel, Switzerland) · 2026Article
- Bedside cognitive screening to detect dementia and predict poor outcomes in hospitals.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Impact of orthogeriatric assessment on mortality in patients with periprosthetic hip fractures: a prospective study.Aging clinical and experimental research · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Short Portable Mental Status Questionnaire (SPMSQ) is a brief instrument designed to evaluate cognitive impairment in older adults. This study evaluates the validity and reliability of the Turkish SPMSQ and determines optimal cut-off values.
methodsPatients aged 65 years and older were enrolled consecutively. Following the translation and cultural adaptation procedure, the Turkish versions of the SPMSQ and Standardised Mini Mental State Examination (SMMSE) were administered to evaluate cognitive status. The SPMSQ's diagnostic accuracy was evaluated by calculating the area under ROC curve (AUC).
resultsA total of 197 patients were included, comprising 48 with dementia and 149 controls. In 67% of the study population, total education time was under five years. ROC analysis of the overall study population identified an optimal cut-off point of the SPMSQ for differentiating dementia at ≥ 4 errors, yielding a sensitivity of 83.3% and specificity of 90.6% (AUC: 0.949). The cut-off point was determined as ≥ 4 errors for patients with ≤ 5 years of education time (sensitivity: 87.2%, specificity: 84.9%, AUC: 0.933) and ≥ 3 errors for patients with > 5 years of education time (sensitivity: 100%, specificity: 98.2%, AUC: 0.997). The SPMSQ and SMMSE scores showed a significant positive correlation (r = 0.661, p < 0.001). The cut-off point for the SMMSE was ≤ 25, demonstrating 83.3% sensitivity and 97.3% specificity, with an AUC of 0.947. This was not statistically different from the SPMSQ AUC (p = 0.93).
conclusionThe SPMSQ is a reliable instrument for dementia screening in older adults and is not inferior to SMMSE. These findings suggest that the SPMSQ can be effectively utilized in primary care and geriatric clinics as a quick and reliable cognitive screening tool, especially in populations with varying education levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.